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Plant-unique membrane receptor kinases with leucine-rich repeat
ectodomains (LRR-RKs) can sense small molecule, peptide, and protein
ligands. Many LRR-RKs require SERK-family coreceptor kinases for
high-affinity ligand binding and receptor activation. How one
coreceptor can contribute to the specific binding of distinct ligands
and activation of different LRR-RKs is poorly understood. Here we
quantitatively analyze the contribution of SERK3 to ligand binding
and activation of the brassinosteroid receptor BRI1 and the peptide
hormone receptor HAESA. We show that while the isolated recep-
tors sense their respective ligands with drastically different binding
affinities, the SERK3 ectodomain binds the ligand-associated recep-
tors with very similar binding kinetics. We identify residues in the
SERK3 N-terminal capping domain, which allow for selective steroid
and peptide hormone recognition. In contrast, residues in the SERK3
LRR core form a second, constitutive receptor–coreceptor interface. Ge-
netic analyses of protein chimera between BRI1 and SERK3 define that
signaling-competent complexes are formed by receptor–coreceptor
heteromerization in planta. A functional BRI1–HAESA chimera sug-
gests that the receptor activation mechanism is conserved among
different LRR-RKs, and that their signaling specificity is encoded in
the kinase domain of the receptor. Our work pinpoints the relative
contributions of receptor, ligand, and coreceptor to the formation
and activation of SERK-dependent LRR-RK signaling complexes reg-
ulating plant growth and development.
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Brassinosteroids are growth-promoting hormones with keyroles in plant development (1). They are sensed by the re-
ceptor kinase with leucine-rich repeat ectodomain (LRR-RK)
BRASSINOSTEROID INSENSITIVE 1 (BRI1) that is composed
of a LRR ectodomain, a single membrane-spanning helix, and a
cytoplasmic kinase module (2, 3). BRI1 directly binds brassinosteroids
including the potent brassinolide (BL) (4). The steroid binding
site is formed by the BRI1 LRR core and by the island domain
inserted between LRRs 21 and 22 (5, 6). Steroid binding creates a
docking platform for the LRR ectodomain of a member of the
SOMATIC EMBRYOGENESIS RECEPTOR KINASE (SERK)
family of coreceptor kinases (SI Appendix, Fig. S1) (6–9). BRI1
forms a ligand-dependent heterodimeric complex with a SERK
protein in vitro, with the SERK N-terminal capping domain
completing the steroid binding pocket (10–12). Receptor–coreceptor
complex formation at the cell surface brings the cytoplasmic
domains of BRI1 and SERK in close proximity, allowing for
transphosphorylation of the two kinases and activation of the
brassinosteroid signaling pathway (11, 13, 14). The sequence-
related LRR-RK HAESA shares the overall architecture with
BRI1 but lacks the island domain (15). HAESA and HAESA-
LIKE 2 (HSL2) bind the peptide hormone INFLORESCENCE
DEFICIENT IN ABSCISSION (IDA) to trigger abscission of floral
organs in Arabidopsis and both receptors associate with SERKs in
an IDA-dependent manner (16–18). HAESA/HSL2 and BRI1 bind
drastically different ligands using different surface areas of their
ectodomains. However, both receptors rely on the same SERK
proteins for activation and the three-dimensional structures of the
active signaling complexes are remarkably similar (11, 17, 19) (Fig.
1A). In addition, SERK proteins have been genetically and bio-
chemically implicated in many other LRR-RK signaling pathways
(20). How few SERK proteins allow for sensing of many different
small molecule, peptide, and protein ligands and to the activation
of their cognate receptors remains to be investigated. Here we
analyze how SERKs can contribute to the specific binding of BL
and IDA and to the activation of BRI1 and HAESA.
Results
A structural superposition of the previously reported BRI1–
BL–SERK1 and HAESA–IDA–SERK1 complexes using the SERK1
ectodomain as reference [root mean square deviation (rmsd) is∼0.6 Å
comparing 185 corresponding Cα atoms] reveals that SERKs bind
BRI1 and HAESA in similar positions, despite their drastically
different ligand binding sites (Fig. 1A) (11, 17, 20). To characterize
the interactions of BRI1 and HAESA with their ligands and co-
receptors, we determined binding kinetics using a label-free surface
biosensor based on grating-coupled interferometry (GCI) (Mate-
rials and Methods) (21). In addition, steady-state binding constants
were derived from isothermal titration calorimetry (ITC) experi-
ments. We found that BL binds BRI1 with a dissociation constant
(KD) of ∼10 nM in GCI assays, similar to the previously reported
binding affinity for radio-labeled BL interacting with BRI1-containing
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Fig. 1. Two distinct SERK surface patches contribute to formation of different LRR-RK complexes. (A, Center) Structural superposition of BRI1–BL–SERK1 (PDB ID 4LSX)
and HAESA–IDA–SERK1 (PDB ID 5IYX) complex structures, using the SERK1 ectodomain as reference (rmsd is ∼0.6 Å comparing 185 corresponding Cα atoms). Shown
are Cα traces of the BRI1 LRR domain (blue, island domain in dark blue), the HAESA LRR domain (orange), the SERK1 ectodomain (gray) and the steroid (blue) and
peptide (orange) ligands in surface representation, respectively. (A, Left) Close-up view of the BRI1–BL–SERK1 complex, highlighting the two distinct interaction
surfaces and including selected interface interactions. BL is shown in bond representation (yellow). (A, Right) Details of the HAESA–IDA–SERK1 interface, with IDA
shown in bonds representation (yellow). SERK residue numbering is according to Arabidopsis SERK3. (B) Grating-coupled interferometry (GCI)-derived binding kinetics
for BRI1 and HAESA vs. their ligands and SERK3. Shown are sensorgrams with data in red and their respective fits in black (Materials andMethods). Table summaries of
kinetic parameters are shown (ka, association rate constant; kd, dissociation rate constant; KD, dissociation constant). (C) Isothermal titration calorimetry (ITC) of the
BRI1 LRR domain vs. wild-type and mutant SERK3 ectodomains and in the presence of BL. (D) ITC of the HAESA LRR domain vs. SERK3 proteins and in the presence of
IDA. Table summaries for dissociation constants (KD) and binding stoichiometries (N) are shown (± fitting error; n.d., no detectable binding).
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plant membrane fractions (Fig. 1B) (4). This tight interaction of
the steroid with its receptor is characterized by a fast association
rate (ka ∼ 1·106 M−1·s−1) and a relatively slow dissociation rate
(kd ∼ 1·10−2·s−1). HAESA, in contrast, binds the IDA peptide with
a KD of ∼30 μM (Fig. 1B), which is in good agreement with the
previously reported KD determined by ITC (17). IDA rapidly as-
sociates with its receptor (ka ∼ 6·104 M−1·s−1), but in contrast to the
steroid hormone the peptide has a fast dissociation rate (kd ∼ 2 s−1).
Our kinetic analyses reveal that BRI1 and HAESA have evolved
distinct modes of ligand binding, allowing them to sense steroid
and peptide ligands with very different binding kinetics.
We assessed binding of the coreceptor SERK3 to the ligand-
bound BRI1 and HAESA ectodomains. SERK3 is a bona fide
BRI1 and HAESA coreceptor (8, 19, 22) and its ectodomain
can be produced in sufficient quantities for biochemical studies
(SI Appendix, Fig. S2). BRI1 shows no detectable binding to
SERK3 in the absence of BL in vitro (11). In the presence of BL,
SERK3 binds BRI1 with a KD of ∼0.7 μM (GCI) or ∼0.2 μM
(ITC), and with 1:1 stoichiometry (Fig. 1 B and C). SERK3 binds
HAESA–IDA with a KD of ∼0.2–1.5 μM as concluded from ITC
(Fig. 1D) or GCI (Fig. 1B) experiments, respectively. The HAESA
coreceptor SERK1 shows similar binding affinities (17). The ki-
netic parameters derived from the GCI experiments indicate that
SERK3 binds BRI1 and HAESA in similar ways, with a relatively
slow dissociation rate (kd ∼ 1–3 × 10−2·s−1) (Fig. 1B). The observed
dissociation rates for SERK3 binding to BRI1/HAESA may be
sufficiently long to allow for the receptor and coreceptor kinase
domains to transphosporylate and activate each other in the cytosol
(11, 13), as previously speculated (20).
We next analyzed which SERK residues interact with either the
ligand or the cognate receptor in the previously reported BRI1–
BL–SERK1 (11) and HAESA–IDA–SERK1 (17) complexes.
Residues originating from the SERK N-terminal capping domain
are in direct contact with the steroid and the peptide hormone, but
different residues are used to recognize the respective ligands
(Fig. 1A) (11, 17). In the case of BRI1, Phe60 (all amino acid
numbering refers to SERK3) establishes a π-stacking interaction
with the C ring of brassinolide, while side-chain and main-chain
atoms from His61 and Trp59 are hydrogen bonding with the 2α–
3α diol moiety of the ligand (6, 11, 12). In the case of HAESA,
SERK residues Thr52 and Val54 form main-chain contacts with
the conserved C terminus of the peptide hormone, with Phe60 and
His61 not being part of the IDA binding site (Fig. 1A) (17). Mu-
tation of Phe60 and/or His61 to Ala completely disrupts binding of
SERK3 to BRI1–BL, suggesting that interactions between co-
receptor and steroid hormone are critical for receptor–coreceptor
complex formation (Fig. 1C and SI Appendix, Fig. S3). Importantly,
SERK3F60A/H61A can still bind HAESA–IDA with moderately re-
duced affinity (Fig. 1D and SI Appendix, Fig. S3).
As IDA establishes only main-chain contacts with the SERK3
N-terminal cap loop, we replaced either Thr52 or Val54 with a
bulky phenylalanine. While SERK3T52F still binds BRI1 and
HAESA with wild-type affinity (SI Appendix, Fig. S3), mutation of
Val54 to Phe selectively reduces binding of the mutant SERK3
protein to HAESA, but not to BRI1 (Fig. 1B). Thus, structure-based
point mutations in SERK3 can selectively inhibit binding to either
BRI1 or HAESA, highlighting that different surface patches in the
SERK N-terminal cap can indeed allow for the sensing of specific
ligands in different LRR-RK complexes (Fig. 1) (11, 17, 20).
In addition to SERKs forming part of the steroid and peptide
hormone binding site, a direct receptor–coreceptor interface can
be observed in the ternary complexes (11, 12, 17). In the case of
BRI1, the interface involves SERKY100 that contacts BRI1Q747.
SERKY124 and SERKR146 are making extensive polar interac-
tions with BRI1E749. Phe144 in SERKs forms hydrophobic con-
tacts with BRI1Y765 (Fig. 1A). These residues are invariant among
Arabidopsis SERK1–4 and among SERKs from other species,
establish similar contacts in the HAESA–IDA–SERK1 complex
(Fig. 1A and SI Appendix, Fig. S1) (17), and are part of the receptor–
coreceptor interface of related peptide hormone receptor complexes
(23–25). Mutation of SERK3F144 to alanine has no drastic effect on
BRI1–BL–SERK3 and HAESA–IDA–SERK3 interaction, but a
SERK3Y100A/Y124A double mutant shows reduced binding to either
BRI1–BL or HAESA–IDA (Fig. 1 and SI Appendix, Fig. S3). Thus,
two different surface areas of the SERK ectodomain contribute to
LRR-RK ligand sensing and complex formation.
To assess the contribution of the SERK mutations analyzed
in vitro to brassinosteroid signaling, we created stable trans-
genic lines expressing either wild-type or mutant SERK3 from a
genomic construct under control of its native promoter and in a
serk1-1 serk3-1 mutant background (SI Appendix, Table S1).
Individual lines showing similar SERK3 protein levels were se-
lected for subsequent analysis (compare SI Appendix, Fig. S4A).
We did not quantify the effects of SERK3 point mutations on
HAESA-mediated floral abscission, as detection of weak phe-
notypes is difficult in the established petal break-strength assay
(17) and because higher-order SERK mutants display pleiotropic
phenotypes at flowering stage (19, 26). The ability to complement
the serk1 serk3 brassinosteroid signaling phenotype was evaluated
in a quantitative hypocotyl growth assay (SI Appendix, SI Methods).
In agreement with our biochemical experiments, mutation of Phe60
and/or His61 to alanine inactivates SERK3 brassinosteroid co-
receptor function in planta (Fig. 2 A and B and SI Appendix, Fig. S5)
and disrupts receptor–coreceptor complex formation in vivo,
as judged from coimmunoprecipitation (co-IP) experiments (Fig.
2D). Mutation of SERK3 residues targeting the direct receptor–
coreceptor interface results in moderate-to-severe brassinosteroid
signaling defects, with SERK3Y100A/Y124A having the strongest effect
(Fig. 2 A and B and SI Appendix, Fig. S5). This is in line with our
biochemical findings, and our in vivo co-IPs confirm an important
contribution of this direct receptor–coreceptor interface to BRI1 sig-
naling complex integrity (Figs. 1C and 2D and SI Appendix, Fig. S3).
We next tested in a formal genetic way whether the receptor–
coreceptor heteromers observed in vivo, in biochemical assays and
in crystals are required for brassinosteroid signal activation (11, 14,
27). We created protein chimera between BRI1 and SERK3, in
which the kinase domain of the receptor is swapped with that of the
coreceptor and vice versa and expressed them under the control of
either the BRI1 or SERK3 promoter in Arabidopsis (Fig. 3A and SI
Appendix, Figs. S4 and S6 and Tables S1 and S4). Expression of
both chimeric constructs together partially complements the bri1-
301 (SI Appendix, Fig. S7) mutant in phenotypic and quantitative
assays (28) (Fig. 3 B and C and SI Appendix, Figs. S4 and S6). In-
dividual chimera cause dominant negative effects, corresponding to
the mutant phenotype of their respective ectodomain: o(utside)
BRI1–i(nside)SERK3 alone causes a bri1 mutant phenotype (Fig.
3B and SI Appendix, Fig. S6). oSERK3–iBRI1 plants are dwarf and
show early senescence, reminiscent of serk1 serk3 serk4 triple mu-
tants (Fig. 3B and SI Appendix, Figs. S4 and S6). Together, these
experiments support an essential role for BRI1–SERK heteromers
in brassinosteroid signaling.
The structural and biochemical similarities between the BRI1–
BL–SERK and HAESA–IDA–SERK signaling complexes promp-
ted us to investigate whether the receptor activation mechanism is
conserved among these pathways in planta (Fig. 1A). We com-
plemented a hae hsl2 mutant, which shows strong floral abscission
defects (18, 29), with a chimeric receptor, in which the BRI1
ectodomain is fused to the HAESA cytoplasmic domain and
expressed under control of the HAESA promoter (Fig. 4A and
SI Appendix, Fig. S6 and Tables S1 and S2). We found that in
contrast to a kinase-inactive version (HAESAD837N), functional
chimera can complement the hae hsl2 abscission phenotype (Fig.
4 B and C). Notably, expression of full-length BRI1 under the
control of the HAESA promoter does not induce floral abscission
in the hae hsl2 mutant (SI Appendix, Fig. S8). We hypothesized
that endogenous brassinosteroids bind to the oBRI1 ectodomain
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in the Arabidopsis abscission zone and allow for SERK complex
formation and HAESA signaling. To test this hypothesis, we gen-
erated a BRI1–HAESA protein chimera, in which the ectodomain
carries the Gly644Asp missense mutation, which has been pre-
viously characterized in bri1-6 mutants (30). Brassinosteroid bind-
ing is disrupted in BRI1G644D in in vitro binding assays (SI Appendix,
Fig. S9). A 2.6-Å crystal structure of the mutant protein revealed
that the mutation does not affect the overall structure of BRI1 and
leaves the conformation of the island domain intact, making the
Gly644Asp mutation an ideal tool to specifically interfere with the
ligand binding function of BRI1 in planta (SI Appendix, Fig. S9 and
Table S3). Importantly, oBRI1G644D–iHAESA cannot complement
the hae hsl2 mutant phenotype, suggesting that indeed brassinos-
teroid sensing and complex formation occurs in the abscission zone.
Our oBRI1–iHAESA chimera indicates that the cytoplasmic sig-
naling specificity of HAESA is encoded in its kinase domain and
not in its extracellular domain.
Discussion
The five SERKs in Arabidopsis have emerged as essential coreceptor
kinases for different LRR-RK signaling pathways, controlling plant
growth, development, and immunity (20). In the known LRR-RK–
SERK complex structures, residues originating from the SERK
N-terminal capping domain contact different small molecule and
peptide ligands when bound to their cognate receptor, while the
SERK LRR core forms variable interactions with the C-terminal
half of the respective ectodomain of the receptor (11, 12, 17, 23–25).
Here, we used the SERK-dependent LRR-RKs BRI1 and
HAESA to assess the relative contributions of both coreceptor
interaction surfaces to high-affinity ligand sensing, to complex for-
mation, and to complex stability.
In the present study, we focused on analyzing SERK residues
contributing to LRR-RK complex formation. We found that dif-
ferent residues from the SERK N-terminal capping domain in-
teract with both the steroid hormone BL and the peptide hormone
IDA and we could generate SERK3 mutants that selectively bind
either BRI1–BL or HAESA–IDA. We speculate that these resi-
dues allow SERKs to discriminate between ligand-associated and
apo forms of their cognate receptors. However, the sequence motifs
identified in our study are not uniquely used for BRI1 or HAESA
recognition: The SERK3 Phe60/His61-containing surface patch
critical for interaction with BRI1 is also important for SERK re-
cruitment to the plant phytosulfokine receptor, another island-domain
containing LRR-RK (24). In addition, the SERK3 Thr52–Val54 loop
is not only in direct contact with the C terminus of the peptide
hormone IDA, but also mediates interaction with the LRR-RK
peptide ligands flg22 (23), Pep1 (31), RGF (32), and CLE41 (25).
This suggests that very different ligands are recognized by SERKs
using only few invariant structural motifs (33). The requirement of
several conserved surface patches in SERK proteins interacting
with different ligands on one hand, and establishing direct complex
interactions on the other hand, may rationalize why the SERK
ectodomain sequences are highly conserved throughout plant evo-
lution (SI Appendix, Fig. S1). Sequence variation alone thus cannot
explain the fact that SERKs act only partially redundant in various
developmental and immune signaling pathways, which may rather
be caused by differences in expression and/or localization to specific
membrane (nano) domains (34, 35).
The interaction of LRR-RK ectodomains has been quantified
for selected ligands with dissociation constants spanning several
orders of magnitude, ranging from the midmicromolar (17, 24)
to the low-nanomolar range (32, 36, 37). In contrast, the reported
KDs for the ligand-dependent SERK association with different
receptors are very similar (∼0.2–1.5 μM) (17, 25). This indicates
that differently shaped ligand binding pockets in LRR-RKs allow
for specific sensing of chemically diverse ligands, but that the
mode of coreceptor recruitment is conserved among the different
signaling pathways. We characterized a second, direct receptor–
coreceptor interface and found that it strongly contributes to
BRI1–SERK3 complex stability (Fig. 1 and SI Appendix, Fig. S3).
We speculate that SERKs target ligand-bound LRR-RKs using
their N-terminal capping domain, and then form a larger, zipper-
like interface with the receptor. The second, constitutive interface
may stabilize the signaling-competent receptor–ligand–coreceptor
complex. In this respect, it is of note that the dissociation rate kd
for IDA binding to the isolated HAESA ectodomain is much
faster than the dissociation of SERK3 from the HAESA–IDA
complex (Fig. 1B). Together with the structural observation that
SERKs bind on top of LRR-RK ligand binding sites, this suggests
that a main function of the coreceptor may be to slow down
Fig. 2. Mutations in the SERK3 ligand binding and receptor interfaces dif-
ferentially impact SERK3 function and complex formation in vivo. (A) Hypocotyl
growth assay in the presence and absence of the brassinosteroid biosynthesis
inhibitor brassinazole (BRZ), from seedlings grown for 5 d in the dark. Serk1-1
serk3-1 mutants are BRZ hypersensitive and this phenotype can be com-
plemented by expressing SERK3 in the mutant background (Col-0, untrans-
formed wild type, n = 50). (B) Quantification of the data from A. The log-
transformed endpoint hypocotyl length was analyzed by a mixed effects model
for the ratio of the transgenic lines vs. wild type, allowing for heterogeneous
variances. The ratio of the untreated and BRZ-treated hypocotyl length was
calculated for wild type (rwt) and each mutant line (rm); the ratio of this ratio
for wild type divided by the ratio for a given mutant line results in the ratio of
ratios (RR = rwt/rm; CI, confidence interval). (C) Coimmunoprecipitation (Co-IP)
of lines shown in A. SERK3:HA was immunoprecipitated from plant protein
extracts using an anti-HA antibody (IP-HA) and BRI1 was detected with an anti-
BRI1 antibody (14) in the IP elution.
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dissociation of ligands from the receptor. Our work reveals that
SERKs have evolved as adapter proteins that allow LRR-RKs to
transduce information across membranes without the need for
major conformation rearrangements.
The analysis of BRI1–SERK3 protein chimera in stable trans-
genic lines now provides formal genetic support for a heteromeric
brassinosteroid signaling complex, extending previous studies on
FLS2–SERK3 chimera analyzed in a transient expression system (38).
The observation that expression of oBRI1–iSERK3 or oSERK3–
iBRI1 chimera in isolation causes dominant negative growth
phenotypes is likely due to their ability to form signaling incompetent
complexes with endogenous LRR-RK pathway components. It is of
note that our oSERK3–iBRI1 phenotypes are reminiscent of those
caused by expression of the isolated SERK3 ectodomain (39). Our
BRI1–HAESA chimera can rescue abscission defects in hae hsl2
mutant plants, suggesting that the activation mechanisms of BRI1
and HAESA are highly similar, and that the kinase domain of the
receptor encodes the cytoplasmic signaling specificity of LRR-RK
complexes. The recent finding that the rice immune receptor XA21
requires SERKs for activation (40) now rationalizes the earlier ob-
servation that a BRI1–XA21 chimera can trigger immune signaling
upon BL sensing in rice cells (41). Based on our and previous find-
ings (38, 41), LRR-RK receptor chimera could help in defining the
functions of presently orphan receptor kinases and may represent
useful tools to modulate plant growth and development in crops.
In conclusion, a ligand-induced and SERK-stabilized receptor–
coreceptor heterodimer represents the minimal signaling unit of
many LRR-RK complexes at the cell surface. It will now be in-
teresting to define at the structural level, how the cytoplasmic ki-
nase domains of receptor and coreceptor interact with each other
in the cytosol. The detailed analysis of these interactions may en-
able us to understand the cytoplasmic signaling specificity of dif-
ferent LRR-RK pathways, and potentially, the signaling cross-talk
between them (42).
Materials and Methods
See SI Appendix, SI Materials and Methods for complete details.
Grating Coupled Interferometry. GCI experiments were performed with the
Creoptix WAVE system (Creoptix AG), a label-free surface biosensor (21). The
interaction between the BRI1 ectodomain and BL was measured using a 2PCH
WAVEchip (long polycarboxylate matrix; Creoptix AG), while all other experi-
ments were performed on a 2PCP WAVEchip (quasiplanar polycarboxylate sur-
face; Creoptix AG). Chips were conditioned using borate buffer (100 mM sodium
borate, pH 9.0, 1 M NaCl; Xantec), and the respective ligands were immobilized
on the chip surface via a standard amine-coupling protocol, which consisted of
a 7-min activation with a 1:1 mix of 400 mM N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride and 100 mM N-hydroxysuccinimide (both
Xantec), followed by injection of the ligands BRI1 or HAESA (1–50 μg/mL) in
BL
Chimaera bri1-301
pBRI1::
oBRI1-iSERK3 /  
~WT
pSERK3::
oSERK3-iBRI1 / 
~WT
serk1-3 serk3-1 
serk4-1Col-0
oBRI1-iSERK3, 
oSERK3-iBRI1 / 
bri1-301
BA C
BRI1
SERK3
BL
Wildtype
SERK3
BRI1
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together (Bottom Left). The expression of isolated chimera results in a dominant negative growth phenotype (Bottom Middle and Right). ∼WT corresponds to
pBRI1::BRI1:mCitrine/bri1-null. (Scale bar, 1 cm.) (C) Hypocotyl growth assay in the presence and absence of BRZ (compare Fig. 2A). bri1-301 is hypersensitive to
BRZ, a phenotype that is partially complemented by the expression of oBRI1–iSERK3 and oSERK3–iBRI1. Quantifications are shown, analyzed as in Fig. 2B.
A
HAESA-signalling
BRI1
BL
SERK
Brassinolide -
perception
0
1
2
3
gr
am
 e
qu
iva
len
ts
1 2 3 4 5 6 7 8 10
Col-0
oBRI1-iHAESA / hae hsl2
oBRI1-iHAESAD837N / hae hsl2
oBRI1G644D-iHAESA / hae hsl2
hae hsl2
Col-0 hae hsl2
oBRI1-
iHAESA / 
hae hsl2
oBRI1-
iHAESAD837N / 
hae hsl2
oBRI1G644D-
iHAESA / 
hae hsl2
B
C
H
AE
SA
position on inﬂorescence
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10 mM sodium acetate, pH 5.0 (Sigma) until the desired density was reached,
and quenched with 1 M ethanolamine, pH 8.0 for 7 min (Xantec). Since
SERK3 showed nonspecific binding on the surface, BSA (0.5% in 10 mM sodium
acetate, pH 5.0; BSA from Roche) was used to passivate the surface between
BRI1/HAESA injection and ethanolamine quenching. Kinetic analysis of the
BRI1–BL interaction was performed at 25 °C with a 1:4 dilution series (five
dilutions in duplicates) from 0.4 μM BL in sodium citrate buffer, pH 5.0, using
citrate buffer, pH 5.0, as running buffer, blank injections for double referenc-
ing, and DMSO calibration for bulk correction. A typical kinetic analysis of the
SERK3 interaction was performed at 25 °C with a 1:2 dilution series from 2 μM
in citrate buffer, pH 5.0, with 100 nM BL or 20 μM IDA in 20mM sodium citrate,
pH 5.0, 250 mM NaCl, blank injections for double referencing, and DMSO
calibration for bulk correction. For BRI1 interaction experiments, the running
buffer was supplemented with 100 nM BL while IDA was supplied only in the
blanks and samples. Data correction and analysis was performed with the
Creoptix WAVEcontrol software (corrections applied: X and Y offset, DMSO
calibration and double referencing). Data were fitted to either one-to-one
binding models or mass-transport limited models, using bulk correction.
ITC. ITC experiments were performed at 25 °C using a Nano ITC (TA Instru-
ments) with a 1.0-mL standard cell and a 250-μL titration syringe. Proteins
were gel filtrated into ITC buffer (20 mM sodium citrate, pH 5.0, 150 mMNaCl)
and Y-IDA (YVPIPPSA-Hyp-SKRHN) was dissolved in ITC buffer. A 10-mM BL
stock solution in 100% (vol/vol) DMSO was diluted into ITC buffer. A typical
experiment consisted of injecting 10-μL SERK3 wild-type or mutant protein
aliquots (∼170 μM) into ∼17 μM BRI1 + 100 μM brassinolide or ∼20 μMHAESA +
200 μM IDA in the cell at 150-s intervals. ITC data were corrected for the heat
of dilution by subtracting the mixing enthalpies for titrant solution injections
into protein-free ITC buffer. Data were analyzed using the NanoAnalyze
program (version 3.5) as provided by the manufacturer.
Plant Material and Generation of Transgenic Lines. SERK3 and BRI1 were
amplified from Arabidopsis thaliana (ecotype Col-0) genomic DNA and
mutations were introduced by site-directed mutagenesis (SI Appendix, Table
S4). Synthetic genes were constructed for the BRI1–SERK3 and BRI1–HAESA
chimera (Invitrogen GeneArt) (SI Appendix, Fig. S4 and Table S1). Binary
vectors were assembled using the multisite Gateway technology (Thermo
Fisher Scientific). All constructs were introduced into Agrobacterium tumefaciens
strain pGV2260, and Arabidopsis plants were transformed using the floral dip
method (43). Plants were transformed with two vectors at the same time to
create double transgenic lines containing pBRI1::oBRI1–iSERK3:mCherry and
pSERK3::oSERK3–iBRI1:mCitrine. GABI_134E10 was used as a bri1-null allele
(10), plants were grown in 50% humidity, 21 °C, in a 16-h light/8-h dark cycle,
and analyzed in T3 generation.
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